Moderna, Inc.

NASDAQ (USD): Moderna, Inc. (MRNA)

Last Price

104.46

Today's Change

+3.05 (3.00%)

Day's Change

99.30 - 105.43

Trading Volume

2,611,365

Overview

Market Cap

39 Billion

Shares Outstanding

382 Million

Avg Volume

3,762,241

Avg Price (50 Days)

100.35

Avg Price (200 Days)

98.98

PE Ratio

-8.47

EPS

-12.33

Earnings Announcement

02-May-2024

Previous Close

101.41

Open

102.79

Day's Range

99.3 - 105.43

Year Range

62.55 - 142.79

Trading Volume

3,090,290

Price Change Highlight

1 Day Change

3.01%

5 Day Change

1.88%

1 Month Change

-0.92%

3 Month Change

2.49%

6 Month Change

32.83%

Ytd Change

-7.15%

1 Year Change

-24.38%

3 Year Change

-39.84%

5 Year Change

322.91%

10 Year Change

461.61%

Max Change

461.61%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 4 of 4 comments

WorldWideInvestor

No one comment here?

2020-06-29 22:34

WorldWideInvestor

Alah Moderna have vaccine lor

2020-06-29 22:34

WorldWideInvestor

If Moderna have vaccnine then will be expensive

2020-06-29 22:35

WorldWideInvestor

All of you huat ahh

2020-06-29 22:35

Post a Comment